Cessation Therapeutics, Inc. logo

Cessation Therapeutics, Inc. jobs and careers

San Diego, CA, United States

About Cessation Therapeutics, Inc.

Cessation Therapeutics provides therapeutics for an addiction-free through immunotherapy-based biotech innovation.Cessation Therapeutics is developing novel immunotherapy vaccine candidates and small molecules with the objective of helping millions of families overcome the opioid, heroin, morphine, fentanyl, alcohol and nicotine addiction usedisorders. Cessation Therapeutics is currently developing heroin, opioid and fentanyl addiction vaccines based on the technology licensed from The Scripps Research Institute in La Jolla, California (TSRI) and has commenced planning pre-clinical studies to advance these vaccine candidates into clinical stage.

Founded in 2017 by David Genecov and Mark Pearson.

Founded
2017
Employees
1 to 10
Headquarters
San Diego

Leadership

The top of Cessation Therapeutics, Inc.'s org chart, with how many people report into each leader.

AP

Andy Barrett, PhD

President & Chief Scientific Officer

1 report

DGPhoto of David Genecov

David Genecov

Chief Medical Officer, Co-Founder and Director

PBPhoto of Paul Bremer

Paul Bremer

Vice President, R&d And CMC

Jobs at Cessation Therapeutics, Inc.

No open positions right now. Explore more companies on TheJobsMap.